Pharma intelligence, from the teams who live it.
Thought leadership, blog articles, whitepapers and infographics across scientific writing, brand communications, pharma technology, channel engagement and business intelligence.
Thought Leadership
In-depth perspective on pharma scientific communication and commercial excellence.
ExploreBlog
Shorter takes on the daily realities of pharma writing, brand and PV teams.
Read the blogWhitepapers
Deep strategic papers, gated, emailed on request.
BrowseInfographics
Visual data summaries for fast sharing with HCPs and teams.
ViewNewsletter
Pharma intelligence in your inbox, weekly.
SubscribeRecent thinking.
Why Manuscripts Get Desk-Rejected Before Review (and How to Stop It)
Most desk rejections have nothing to do with the science. They are process failures that are entirely preventable, if you engineer them out before submission.
Read Article Scientific WritingCONSORT and PRISMA Compliance: What Pharma Teams Miss
Reporting guidelines are not a submission checklist. They are a writing architecture, and treating them otherwise is why so many pharma manuscripts stall.
Read Article Pharma TechnologyHow to Choose a Journal Beyond Impact Factor
Impact factor is the worst single metric to select a journal on. Acceptance probability, scope fit and APC reality matter far more.
Read Article Brand CommunicationsScientific Storytelling for Pharma Brand Managers
Strong science does not sell itself. Translating evidence into a brand story the field can use is a discipline, not a creative flourish.
Read Article Brand CommunicationsMLR Compliance in Brand Content: Stop Losing Cycles to Review
MLR is not the enemy of speed. Unmapped claims are. Fix the input and the review bottleneck largely disappears.
Read Article Pharma TechnologyWhy FAERS Data Should Drive PV Resource Planning
PV staffing built on intuition fails at inspection. FAERS-driven drug-risk tiering makes resource plans defensible.
Read Article